Oragenics Inc. (AMEX: OGEN) is 29.18% higher on its value in year-to-date trading and has touched a low of $0.36 and a high of $2.09 in the current 52-week trading range. The OGEN stock was last observed hovering at around $0.52 in the last trading session, with the day’s gains setting it 0.06% off its average median price target of $2.50 for the next 12 months. It is also 76.8% off the consensus price target high of $2.50 offered by 1 analysts, but current levels are 76.8% higher than the price target low of $2.50 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $0.58, the stock is 28.88% and 24.93% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 39.59 million and changing 11.56% at the moment leaves the stock -9.02% off its SMA200. OGEN registered 20.80% gain for a year compared to 6-month loss of -26.36%. The firm has a 50-day simple moving average (SMA 50) of $0.4464 and a 200-day simple moving average (SMA200) of $0.6804.
The stock witnessed a 25.81% gain in the last 1 month and extending the period to 3 months gives it a -2.98%, and is 33.64% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.58% over the week and 9.07% over the month.
Distance from 52-week low is 61.11% and -72.25% from its 52-week high.
Oragenics Inc. (OGEN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Oragenics Inc. (OGEN) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Oragenics Inc. is expected to release its quarterly report on 05/18/2021 and quarterly earnings per share for the current quarter are estimated at -$0.06.The EPS is expected to grow by 57.60% this year.
Oragenics Inc. (OGEN) Top Institutional Holders
24 institutions hold shares in Oragenics Inc. (OGEN), with 4.24M shares held by insiders accounting for 6.94% while institutional investors hold 7.98% of the company’s shares. The shares outstanding are 59.67M, and float is at 56.38M with Short Float at 2.41%. Institutions hold 7.43% of the Float.
The top institutional shareholder in the company is Third Security, LLC with over 4.61 million shares valued at $2.65 million. The investor’s holdings represent 5.96% of the OGEN Shares outstanding. As of Sep 29, 2020, the second largest holder is Vanguard Group, Inc. (The) with 1.42 million shares valued at $0.82 million to account for 1.84% of the shares outstanding. The other top investors are Sara-Bay Financial which holds 1.32 million shares representing 1.70% and valued at over $0.76 million, while Renaissance Technologies, LLC holds 1.04% of the shares totaling 0.81 million with a market value of $0.46 million.
Oragenics Inc. (OGEN) Insider Activity
The most recent transaction is an insider sale by KOSKI ROBERT C, the company’s Director. SEC filings show that KOSKI ROBERT C sold 310,000 shares of the company’s common stock on Dec 22 at a price of $0.43 per share for a total of $0.13 million. Following the sale, the insider now owns 0.78 million shares.
Oragenics Inc. disclosed in a document filed with the SEC on Dec 02 that Hernandez Joseph (10% Owner) sold a total of 5,000,000 shares of the company’s common stock. The trade occurred on Dec 02 and was made at $0.41 per share for $2.05 million. Following the transaction, the insider now directly holds 4.2 million shares of the OGEN stock.
Still, SEC filings show that on Nov 24, Telling Fred (Director) acquired 100,000 shares at an average price of $0.37 for $37000.0. The insider now directly holds 439,538 shares of Oragenics Inc. (OGEN).